HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ibrahim Karadag Selected Research

Noninfiltrating Intraductal Carcinoma (DCIS)

7/2021Evaluation of factors predicting pathologic complete response in locally advanced HER2 positive breast cancer treated with neoadjuvant pertuzumab, trastuzumab and chemotherapy; Real life data.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ibrahim Karadag Research Topics

Disease

5Neoplasms (Cancer)
04/2023 - 03/2021
3Breast Neoplasms (Breast Cancer)
04/2023 - 07/2021
1Ductal Carcinoma
04/2023
1Insulin Resistance
01/2023
1Neoplasm Metastasis (Metastasis)
01/2023
1Inflammation (Inflammations)
03/2022
1Testicular Neoplasms (Testicular Cancer)
03/2022
1Pathologic Complete Response
07/2021
1Noninfiltrating Intraductal Carcinoma (DCIS)
07/2021
1Esophageal Neoplasms (Esophageal Cancer)
03/2021

Drug/Important Bio-Agent (IBA)

2Trastuzumab (Herceptin)FDA Link
04/2023 - 07/2021
2Docetaxel (Taxotere)FDA Link
04/2023 - 03/2021
2pertuzumabIBA
04/2023 - 07/2021
1Paclitaxel (Taxol)FDA LinkGeneric
04/2023
1Triglycerides (Triacylglycerol)IBA
01/2023
1Glucose (Dextrose)FDA LinkGeneric
01/2023
1HDL CholesterolIBA
01/2023
1Indicators and Reagents (Reagents)IBA
03/2022
1Carbon MonoxideIBA
03/2022
1Bleomycin (Blenoxane)FDA LinkGeneric
03/2022
1sinovac COVID-19 vaccineIBA
11/2021
1taxaneIBA
07/2021
1AnthracyclinesIBA
07/2021
1Oxaliplatin (Eloxatin)FDA LinkGeneric
03/2021
1Leucovorin (Folinic Acid)FDA Link
03/2021
1Fluorouracil (Carac)FDA LinkGeneric
03/2021

Therapy/Procedure

2Neoadjuvant Therapy
04/2023 - 07/2021
2Drug Therapy (Chemotherapy)
04/2023 - 07/2021
1BEP protocol
03/2022
1Therapeutics
11/2021
1Chemoradiotherapy
03/2021